EGFR Signaling in Liver Diseases Karin Komposch et al, 2015, IJMS CrossRef
Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy. Ruud Weijer et al, 2017, Cell Mol Life Sci CrossRef
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan James M. Cleary et al, 2017, Invest New Drugs CrossRef
ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy Ozlen Saglam et al, 2017, Cancer Control CrossRef
Gene copy number variation and protein overexpression of EGFR and HER2 in distal extrahepatic cholangiocarcinoma Min Jung Jung et al, 2017, Pathology CrossRef
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma Yun-Fei Xu et al, 2015, WJG CrossRef
The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer Hwajeong Lee et al, 2017, Therap Adv Gastroenterol CrossRef
Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR Caterina Peraldo-Neia et al, 2018, PLoS ONE CrossRef
Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival RODRIGO VIEIRA GOMES et al, 2018, Rev. Col. Bras. Cir. CrossRef
Emerging role of precision medicine in biliary tract cancers James M. Bogenberger et al, 2018, npj Precision Onc CrossRef
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers Angela Lamarca et al, 2018, PLoS ONE CrossRef
The role of tumour microenvironment: a new vision for cholangiocarcinoma Ziyan Chen et al, 2018, J Cell Mol Med CrossRef
Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway Yao-Fei Pei et al, 2019, The American Journal of Pathology CrossRef
Rethink of EGFR in Cancer With Its Kinase Independent Function on Board Rintu Thomas et al, 2019, Front. Oncol. CrossRef
Pertuzumab in gastrointestinal cancer Do-Youn Oh et al, 2016, Expert Opinion on Biological Therapy CrossRef
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? Salvatore Galdy et al, 2017, Cancer Metastasis Rev CrossRef
HER2-targeted therapies - a role beyond breast cancer. Do-Youn Oh et al, 2020, Nat Rev Clin Oncol CrossRef
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis Thomas Albrecht et al, 2019, BMC Cancer CrossRef
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer. Caterina Vivaldi et al, 2020, Oncologist CrossRef
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors Aladdin M. Srour et al, 2020, Bioorganic & Medicinal Chemistry CrossRef
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm Sakti Chakrabarti et al, 2020, Cancers CrossRef
Details of HER2 status in 454 cases of biliary tract cancer Nobuyoshi Hiraoka et al, 2020, Human Pathology CrossRef
Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review Imeshi Wijetunga et al, 2020, Cancers CrossRef
Experimental HER2 targeted therapies for biliary tract cancer Alessandro Rizzo et al, 2020, Expert Opinion on Investigational Drugs CrossRef
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures. Alessandro Rizzo et al, 2020, Cancers (Basel) CrossRef
Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients Patricia García et al, 2020, Cancers CrossRef
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma Patrick L. Garcia et al, 2018, Mol Cancer Ther CrossRef
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells Boonyakorn Boonsri et al, 2020, Cancer Res Treat CrossRef
MicroRNA-1182 and let-7a exert synergistic inhibition on invasion, migration and autophagy of cholangiocarcinoma cells through down-regulation of NUAK1 Xin Pan et al, 2021, Cancer Cell Int CrossRef
Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review Emma-Anne Karlsen et al, 2021, Cells CrossRef
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice? Alice Boilève et al, 2021, Cancers CrossRef
Effect of Photodynamic Therapy on Gemcitabine-Resistant Cholangiocarcinoma in vitro and in vivo Through KLF10 and EGFR Yang Yang et al, 2021, Front. Cell Dev. Biol. CrossRef
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Lauren M Lucas et al, 2022, Pharmacol Rev CrossRef
Design, synthesis, and molecular modeling of quinoline‐based derivatives as anti‐breast cancer agents targeting EGFR/AKT signaling pathway Rasha Z. Batran et al, 2022, Chem Biol Drug Des CrossRef
Systemic Therapy of Cholangiocarcinoma Ruben R. Plentz et al, 2016, Visc Med CrossRef
Different costs of therapeutic resistance in cancer: Short- and long-term impact of population heterogeneity Irina Kareva, 2022, Mathematical Biosciences CrossRef
Tumor Microenvironment and Immunotherapy in Advanced Biliary Tract Cancers Mustafa Korkmaz et al, 2022 CrossRef
Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology Maurizio Capuozzo et al, 2022, IJMS CrossRef
Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays Hwe Hoon Chung et al, 2023, Gut and Liver CrossRef
Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2 Salwa Magdy Eldaly et al, 2023, Chemistry & Biodiversity CrossRef
ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications Wook Jin, 2020, JCM CrossRef
HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment Xiaohong Pu et al, 2024, J Cancer Res Clin Oncol CrossRef